BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strookappe B, Swigris J, De Vries J, Elfferich M, Knevel T, Drent M. Benefits of Physical Training in Sarcoidosis. Lung 2015;193:701-8. [PMID: 26286208 DOI: 10.1007/s00408-015-9784-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gür-Demirel Y, Berendse APC, van Laar JAM, Wijsenbeek MS. Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners. Lung 2018;196:569-75. [PMID: 30088094 DOI: 10.1007/s00408-018-0144-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
2 Zhou Y, Lower EE, Li H, Baughman RP. Clinical management of pulmonary sarcoidosis. Expert Review of Respiratory Medicine 2016;10:577-91. [DOI: 10.1586/17476348.2016.1164602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Crouser ED, Smith RM, Culver DA, Julian MW, Martin K, Baran J, Diaz C, Erdal BS, Hade EM. A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis. Chest 2021:S0012-3692(21)00962-4. [PMID: 34029565 DOI: 10.1016/j.chest.2021.05.031] [Reference Citation Analysis]
4 Barrado-Martín Y, Heward M, Polman R, Nyman SR. Acceptability of a Dyadic Tai Chi Intervention for Older People Living With Dementia and Their Informal Carers. J Aging Phys Act 2019;27:166-83. [PMID: 30160584 DOI: 10.1123/japa.2017-0267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Grongstad A, Spruit MA, Oldervoll LM, Vøllestad NK, Edvardsen A. Pulmonary Rehabilitation in Patients with Pulmonary Sarcoidosis: Impact on Exercise Capacity and Fatigue. Respiration 2020;99:289-97. [PMID: 32131065 DOI: 10.1159/000506295] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yserbyt J, Wells AU. Sarcoidosis: pulmonary manifestations and management. In: Wuyts WA, Cottin V, Spagnolo P, Wells AU, editors. Pulmonary Manifestations of Systemic Diseases. Sheffield: European Respiratory Society; 2019. pp. 404-18. [DOI: 10.1183/2312508x.10015919] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Drent M, Elfferich M, Breedveld E, Vries J, Strookappe B. Benefit of Wearing an Activity Tracker in Sarcoidosis. J Pers Med 2020;10:E97. [PMID: 32842583 DOI: 10.3390/jpm10030097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Strookappe B, De Vries J, Elfferich M, Kuijpers P, Knevel T, Drent M. Predictors of fatigue in sarcoidosis: The value of exercise testing. Respiratory Medicine 2016;116:49-54. [DOI: 10.1016/j.rmed.2016.05.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
9 Thunold RF, Løkke A, Cohen AL, Ole H, Bendstrup E. Patient reported outcome measures (PROMs) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2017;34:2-17. [PMID: 32476819 DOI: 10.36141/svdld.v34i1.5760] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Atkins CP, Jones AP, Wilson AM. Measuring activity in patients with sarcoidosis - a pilot trial of two wrist-worn accelerometer devices. Sarcoidosis Vasc Diffuse Lung Dis 2018;35:62-8. [PMID: 32476881 DOI: 10.36141/svdld.v35i1.5848] [Reference Citation Analysis]
11 Voortman M, Stern BJ, Saketkoo LA, Drent M. The Burden of Neurosarcoidosis: Essential Approaches to Early Diagnosis and Treatment. Semin Respir Crit Care Med 2020;41:641-51. [PMID: 32777849 DOI: 10.1055/s-0040-1710576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Wallaert B, Kyheng M, Labreuche J, Stelianides S, Wemeau L, Grosbois JM. Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage IV sarcoidosis: A randomized controlled trial. Respir Med Res 2020;77:1-7. [PMID: 31855785 DOI: 10.1016/j.resmer.2019.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tavee J, Culver D. Nonorgan manifestations of sarcoidosis. Curr Opin Pulm Med 2019;25:533-8. [PMID: 31365388 DOI: 10.1097/MCP.0000000000000597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Grongstad A, Vøllestad NK, Oldervoll LM, Spruit MA, Edvardsen A. The effects of High- versus Moderate-Intensity Exercise on Fatigue in Sarcoidosis. J Clin Med 2019;8:E460. [PMID: 30959786 DOI: 10.3390/jcm8040460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Atkins C, Wilson AM. Managing fatigue in sarcoidosis - A systematic review of the evidence. Chron Respir Dis 2017;14:161-73. [PMID: 27507833 DOI: 10.1177/1479972316661926] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
16 Nakazawa A, Cox NS, Holland AE. Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis 2017;11:115-28. [PMID: 28150539 DOI: 10.1177/1753465816676048] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
17 Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Comprehensive Care for Patients with Sarcoidosis. J Clin Med 2020;9:E390. [PMID: 32024123 DOI: 10.3390/jcm9020390] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
18 Bonham CA, Strek ME, Patterson KC. From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis. Curr Opin Pulm Med 2016;22:484-91. [PMID: 27379967 DOI: 10.1097/MCP.0000000000000301] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 7.4] [Reference Citation Analysis]
19 Lingner H, Buhr-schinner H, Hummel S, van der Meyden J, Grosshennig A, Nowik D, Schultz K. Short-Term Effects of a Multimodal 3-Week Inpatient Pulmonary Rehabilitation Programme for Patients with Sarcoidosis: The ProKaSaRe Study. Respiration 2018;95:343-53. [DOI: 10.1159/000486964] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
20 Drent M, Strookappe B, Hoitsma E, De Vries J. Consequences of Sarcoidosis. Clinics in Chest Medicine 2015;36:727-37. [DOI: 10.1016/j.ccm.2015.08.013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
21 Kullberg S, Rivera NV, Eriksson MJ, Grunewald J, Eklund A. High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells. Eur Clin Respir J 2020;7:1730137. [PMID: 32158524 DOI: 10.1080/20018525.2020.1730137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 James WE, Judson MA. Therapeutic strategies for pulmonary sarcoidosis. Expert Rev Respir Med 2020;14:391-403. [PMID: 32003264 DOI: 10.1080/17476348.2020.1721284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Gerke AK. Treatment of Sarcoidosis: A Multidisciplinary Approach. Front Immunol 2020;11:545413. [PMID: 33329511 DOI: 10.3389/fimmu.2020.545413] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Grongstad A, Vøllestad NK, Oldervoll LM, Spruit MA, Edvardsen A. The acute impact of resistance training on fatigue in patients with pulmonary sarcoidosis. Chron Respir Dis 2020;17:1479973120967024. [PMID: 33820449 DOI: 10.1177/1479973120967024] [Reference Citation Analysis]
25 Jastrzebski D, Toczylowska B, Zieminska E, Zebrowska A, Kostorz-Nosal S, Swietochowska E, Di Giulio C, Ziora D. The effects of exercise training on lipid profile in patients with sarcoidosis. Sci Rep 2021;11:5551. [PMID: 33692469 DOI: 10.1038/s41598-021-84815-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel) 2021;11:1089. [PMID: 34203584 DOI: 10.3390/diagnostics11061089] [Reference Citation Analysis]
27 van Manen MJG, Wester VL, van Rossum EFC, van den Toorn LM, Dorst KY, de Rijke YB, Wijsenbeek MS. Scalp hair cortisol and testosterone levels in patients with sarcoidosis. PLoS One 2019;14:e0215763. [PMID: 31199799 DOI: 10.1371/journal.pone.0215763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Judson MA. Screening Sarcoidosis Patients for Occult Disease. Semin Respir Crit Care Med 2020;41:741-57. [PMID: 32777855 DOI: 10.1055/s-0040-1709496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Strookappe B, Saketkoo LA, Elfferich M, Holland A, De Vries J, Knevel T, Drent M. Physical activity and training in sarcoidosis: review and experience-based recommendations. Expert Rev Respir Med 2016;10:1057-68. [PMID: 27552344 DOI: 10.1080/17476348.2016.1227244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
30 Herrera-Olivares AM, García-Manso JM, Rodríguez-Gómez I, Ara I, Lucia A, Santalla A. Long-Term Benefits of Tailored Exercise in Severe Sarcoidosis: A Case Report. Int J Environ Res Public Health 2020;17:E9512. [PMID: 33353138 DOI: 10.3390/ijerph17249512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]